These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11495415)

  • 1. Ovarian hyperstimulation after the sole use of a gonadotrophin-releasing hormone agonist (Nafarelin) as a complication of in vitro fertilisation treatment.
    Brett S; Yong PY; Thong KJ
    J Assist Reprod Genet; 2001 Jun; 18(6):353-6. PubMed ID: 11495415
    [No Abstract]   [Full Text] [Related]  

  • 2. Ovarian hyperstimulation caused by a gonadotropin agonist.
    Letterie GS
    Am J Obstet Gynecol; 2000 Mar; 182(3):747. PubMed ID: 10739547
    [No Abstract]   [Full Text] [Related]  

  • 3. Ovarian hyperstimulation: effects of GnRH analogues. Ovarian hyperstimulation syndrome after using gonadotrophin-releasing hormone analogue as a trigger of ovulation: causes and implications.
    Kol S; Lewit N; Itskovitz-Eldor J
    Hum Reprod; 1996 Jun; 11(6):1143-4. PubMed ID: 8671407
    [No Abstract]   [Full Text] [Related]  

  • 4. Ovarian hyperstimulation: effects of GnRH analogues. Does triggering ovulation with gonadotrophin-releasing hormone analogue prevent severe ovarian hyperstimulation syndrome?
    Casper RF
    Hum Reprod; 1996 Jun; 11(6):1144-6. PubMed ID: 8671408
    [No Abstract]   [Full Text] [Related]  

  • 5. Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders.
    Bar-Hava I; Mizrachi Y; Karfunkel-Doron D; Omer Y; Sheena L; Carmon N; Ben-David G
    Fertil Steril; 2016 Aug; 106(2):330-3. PubMed ID: 27114332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotrophin-releasing hormone agonist and ovarian hyperstimulation syndrome in assisted reproduction.
    Mordel N; Schenker JG
    Hum Reprod; 1993 Dec; 8(12):2009-14. PubMed ID: 8150896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem.
    Huber M; Hadziosmanovic N; Berglund L; Holte J
    Fertil Steril; 2013 Nov; 100(5):1270-6. PubMed ID: 23931964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GnRH agonist trigger and a freeze-all strategy to prevent ovarian hyperstimulation syndrome: a retrospective study of OHSS risk and pregnancy rates.
    Atkinson P; Koch J; Ledger WL
    Aust N Z J Obstet Gynaecol; 2014 Dec; 54(6):581-5. PubMed ID: 25476811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone.
    Weissman A; Barash A; Shapiro H; Casper RF
    Hum Reprod; 1998 Dec; 13(12):3421-4. PubMed ID: 9886527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on the prevention of ovarian hyperstimulation syndrome.
    El Tokhy O; Kopeika J; El-Toukhy T
    Womens Health (Lond); 2016 Sep; 12(5):496-503. PubMed ID: 27543490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial.
    Engmann LL; Maslow BS; Kaye LA; Griffin DW; DiLuigi AJ; Schmidt DW; Grow DR; Nulsen JC; Benadiva CA
    J Ovarian Res; 2019 Jan; 12(1):8. PubMed ID: 30684970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes from ovarian hyperstimulation following the sole administration of gonadotrophin-releasing hormone agonist in the context of in vitro fertilization: report of two cases and review of the literature.
    Pinto E; Pinelo S; Osório M; Ferreira C; Serra H; Pires I; Barbosa A; Figueiredo H; Felgueira E; Tavares A
    Gynecol Endocrinol; 2012 Jul; 28(7):545-8. PubMed ID: 22439899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian hyperstimulation: effects of GnRH analogues. Triggering the final stage of ovulation using gonadotrophin-releasing hormone analogues: effective dose, prevention of ovarian hyperstimulation syndrome and the luteal phase.
    Ben-Arie A; Weissman A; Shoham Z
    Hum Reprod; 1996 Jun; 11(6):1146-8. PubMed ID: 8671409
    [No Abstract]   [Full Text] [Related]  

  • 14. Gonadotrophin-releasing hormone agonist trigger and freeze-all strategy does not prevent severe ovarian hyperstimulation syndrome: a report of three cases.
    Gurbuz AS; Gode F; Ozcimen N; Isik AZ
    Reprod Biomed Online; 2014 Nov; 29(5):541-4. PubMed ID: 25246114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and management of ovarian hyperstimulation syndrome.
    Chen CD; Chen SU; Yang YS
    Best Pract Res Clin Obstet Gynaecol; 2012 Dec; 26(6):817-27. PubMed ID: 22647872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports.
    Martínez F; Rodríguez DB; Buxaderas R; Tur R; Mancini F; Coroleu B
    Fertil Steril; 2011 Jun; 95(7):2432.e17-9. PubMed ID: 21513932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing ovarian hyperstimulation with gonadotropin-releasing hormone agonist trigger: is anything perfect?
    Filicori M
    Fertil Steril; 2014 Apr; 101(4):936-7. PubMed ID: 24613536
    [No Abstract]   [Full Text] [Related]  

  • 18. GnRH agonist triggering in high-risk patients.
    Gurbuz AS; Deveer R; Kuçuk M
    Hum Reprod; 2014 Jul; 29(7):1598. PubMed ID: 24781424
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply: GnRH agonist triggering in high-risk patients.
    Iliodromiti S; Nelson SM
    Hum Reprod; 2014 Jul; 29(7):1598-9. PubMed ID: 24781423
    [No Abstract]   [Full Text] [Related]  

  • 20. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
    Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
    Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.